Lonitoclax

Overview

Lonitoclax is a B-cell lymphoma 2 ( Bcl-2 ) inhibitor. Lonitoclax has comparable anti-tumor efficacy to Venetoclax ( HY-15531 ) in both B cell and myeloid malignancy models. Lonitoclax is promising for research of relapsed or refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and certain low-grade lymphomas.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bcl-2 Family

Product Information

• Catalog No.: HY-168983
• CAS No.: 2952589-57-8
• Molecular Formula: C43H45ClN4O5
• Molecular Weight: 733.29
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source